Author

S. J. Kent

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 5 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:cell type annotation· 3 Research Focus:host-pathogen & immune response· 3 Organism:human· 3 Organism:non-human primate· 3 Assay:proteomics· 3 Research Focus:differential expression· 2 Approach:statistical model· 2

Frequent Co-Authors

A. K. Wheatley· 5 shared J. A. Juno· 4 shared H.-X. Tan· 3 shared R. Esterbauer· 3 shared W. S. Lee· 3 shared H. G. Kelly· 2 shared M. Koutsakos· 2 shared A. A. Berry· 1 shared

Activity by Year

2020-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 23 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

5 shared papersImmunology

A. K. Wheatley

Mutual co-authors in cluster

Author profile →

6 papers

Recent·Most cited

Differential cross-reactivity to the influenza B virus haemagglutinin underpins lineage-specific susceptibility between birth cohorts

P. Edler, L. S. U. Schwab, M. Aban, M. Wille, N. Spirason, Y.-M. Deng, M. A. Carlock, T. Ross, J. A. Juno, S. Rockman, A. K. Wheatley, S. J. Kent, I. Barr, D. J. Price, M. Koutsakos

The paper shows that early life exposure to influenza B virus influences cross-reactivity and susceptibility to future isolates, explaining lineage-specific infection patterns across birth cohorts.

bioRxiv · Aug 25, 2023 · PreprintImmunology

Monoclonal antibodies against human coronavirus NL63 spike

M. Conlan, H.-X. Tan, R. Esterbauer, A. Kelly, S. J. Kent, A. K. Wheatley, W. S. Lee

The paper characterises humoral responses and isolates neutralising antibodies against the NL63 coronavirus spike protein in healthy adults.

bioRxiv · Mar 12, 2023 · PreprintMicrobiology

Host Immunity to Mycobacterium tuberculosis Infection is Similar in Simian Immunodeficiency Virus (SIV)-infected, Antiretroviral Therapy-treated and SIV-naïve Juvenile Macaques

E. C. Larson, A. L. Ellis-Connell, M. Rodgers, A. K. Gubernat, J. L. Gleim, R. V. Moriarty, A. J. Balgeman, Y. K. Menezes, C. Ameel, D. J. Filmore, S. M. Pergalske, J. A. Juno, P. Maiello, A. G. White, H. J. Borish, , C. A. Scanga

This study compares host immunity to Mycobacterium tuberculosis in SIV-infected, ART-treated and SIV-naïve juvenile macaques, finding similar TB progression and T cell responses.

bioRxiv · Dec 14, 2022 · PreprintImmunology

Prime-boost protein subunit vaccines against SARS-CoV-2 are highly immunogenic in mice and macaques

H.-X. Tan, J. A. Juno, W. S. Lee, I. Barber-Axthelm, H. G. Kelly, K. M. Wragg, R. Esterbauer, T. Amarasena, F. L. Mordant, K. Subbarao, S. J. Kent, A. K. Wheatley

This study evaluates S and RBD subunit vaccines in mice and macaques, finding S is more immunogenic and boosting enhances neutralizing titers.

bioRxiv · Sep 1, 2020 · PreprintImmunology

Coformulation with tattoo ink for immunological assessment of vaccine immunogenicity in the draining lymph node

I. M. Barber-Axthelm, H. G. Kelly, R. Esterbauer, K. Wragg, A. Gibbon, W. S. Lee, A. K. Wheatley, S. J. Kent, H.-X. Tan, J. A. Juno

The paper develops a method to co-formulate vaccines with tattoo ink to identify vaccine-draining lymph nodes and assess antigen-specific immune responses in non-human primates.

bioRxiv · Aug 27, 2020Immunology

Atypical B cells are a normal component of immune responses to vaccination and infection in humans

H. J. Sutton, R. Aye, A. H. Idris, R. Vistein, E. Nduati, O. Kai, J. Mwacharo, L. Xi, X. Gao, D. Andrews, M. Koutsakos, T. H. O. Nguyen, M. Nekrasov, P. Milburn, A. Ethala, , I. A. Cockburn

This study identifies atypical B cells as a normal part of immune responses to vaccination and infection in humans, showing they are present in both malaria-exposed and healthy individuals.

bioRxiv · May 28, 2020 · PreprintImmunology